Gastroenterology and Hepatology Division Internal Medicine of Medical Faculty North Sumatera University/ Adam Malik Hospital
Faktor AGRESIF Faktor DEFENSIF
- Pepsin - C empedu - Mukus mukosa * Asam * Alkohol - Bikarbonat ion * Obat [NSAID] - Stres [Vaskularisasi mukosa] - Prostaglandin * HP - Radikal bebas - Vaskularisasi membran mukosa
Schwartz 1910 : NO ACID NO ULCER
Faktor lain : - CNS - Heredity - Lingkungan Gg keseimbangan :
Introduction of gastric ulcer : Break of the mucosa extend to muscularis mucosae creater surrounded by acute & chronic inflammatory cell infiltrate Location GU mostly on fundal-antral junction Pathophysiology of GU : Natural adaptive defenses of normal mucosa against injury from the acid & peptic activity gastric juice are overwhelmed by infection H pylori, NSAIDs, psychological stress The other factors acid secretory response, increase vulnerability to erosive, inflammatory or traumatic attack. Patophysiology of GU : Imbalanced of Aggressive factors & defensive factors. Aggressive factors acid + peptic activity + overwhelming factors (H pylori, NSAIDs, psychological stress) Defensive factors change condition of pre epithlial, epithelial & sub- epithelial. Defense mechanism of gastric mucosa : Two levels of defense mechanism : extra mucosal & mucosal. Extra mucosal : acid secreted into the stomach is highly bactericidal. Mucosal : correspond to anatomic organization to gastric wall. Mucosal Defense:
First Line Defense (mucus / bicarbonate barrier) Second Line Defense (epithelial cell mechanisms barrier function of apical plasma membrane) Third Line Defense (blood flow mediated removal of back diffused hydrogen ions and supply of energy) EPITHELIAL CELL INJURY
Mucus-bicarbonate barrier: Columnar epithelial cells secreted protective layer of mucus. Protective effect depend on thickness & quality of mucus Bicarbonate secreted by epithelial cells to neutralized very acidic condition in the lumen H + back diffusion Acid resistant mucosal surface : Gastric mucosal surface have specialized apical surface membrane maintaning pH about 2.0 resist to H+ back diffusion. Tight junction of apical cells acid impermeable. The basolateral cells to acid at pH 5.5, rapid decay of resistance. Restitution of superficially damaged epithelium: The mucoid cap will be promoting hemostasis after superficial injury, limiting the back- diffusion of acid, it facilitates platelet aggregation. When damage is deep, cell proliferation or regeneration involving epithelial cells, fibroblasts, and angiogenesis fill up the mucosal defect. The epithelial restitution and regeneration depend extensively on vascular factors.
Restitution of superficially damaged epithelium:(contd) Cells damaged released mucus to form mucoid cap of cellular debris, mucus & blood components (fibrin) Cells from the gastric pits begin to migrate along the denuded basal lamina the migrating cells form tight junctions, and within 15 minutes to 1 hour, the epithelium is again intact.
Mucosal circulation:
The mucosal blood flow that provides the rapid removal of any substances that may have breached the epithelial barrier, as well as supplying oxygen and nutrients The reactive hyperemia that follows epithelial damage helps protect the mucosa from toxic substances and provides additional buffering capacity in the presence of acid back- diffusion. Mucosal circulation:(contd) The mucosal vascular architecture deliver of bicarbonate to the epithelium: to the basolateral surfaces of parietal cells, exchange of bicarbonate for chloride can be made The bicarbonate is then delivered to the luminal surface, where it diffuses into the epithelial cells, to be actively secreted in exchange for chloride ions.
Mucosal immune response(1) The inflammatory changes by the release of cytokines & products of the arachidonic acid & recruit and activate PMN cells, monocytes, and mast cells. Secretion of immunoglobulin A (IgA) by mast cells in the lamina propria. Local IgG may reach the lumen by passive intercellular diffusion & against infecting micro- organisms immediately adjacent to the lumen, under the protective umbrella of the mucus-bicarbonate barrier.
Mucosal immune response(2) Cell-mediated immune responses in the gastrointestinal epithelium and lamina propria are also quite specialized ( CD8+ & CD4+) Significant numbers of intra-epithelial lymphocytes rearrange their T-cell receptors in the gut epithelium To express potentially autoreactive repertoires, in some circumstances they may become active and contribute to epithelial damage. Neural and muscular defenses:
The ENS contain peptide neurotransmitters reflex vasodilation in response to certain barrier-breaching toxins as well as to back-diffusion of acid Nonvascular smooth muscle (muscularis mucosae) maintain mucosal integrity bymodulating the flow of blood through the arterioles and collecting venules that pass through it to and from the mucosa.
Prostaglandins biological actions :
Modulate blood flow Effect gastrointestinal smooth-muscle contractility Modulate epithelial secretion by mediating ion transport responses to luminal antigen and stimulating the gastric epithelial secretion of bicarbonate Inhibit histamine-stimulated acid secretion through direct, receptor-mediated effects on the parietal cell.
Pathway of Arachidonic acid metabolism
Prostaglandins cytoprotections:
Increased mucus and bicarbonate secretion Increased blood flow Maintenance of endothelial integrity Inhibition of granulocytic secretions Stabilization of mast cells and lysosomal membranes Reduction of gastric contractility.
Epithelial function related to vascular, neural & immune factors Gastric mucosal protection : Cytoprotection, mucosal resistant influenced by some factors internal or external Local or systemic pathway The role of PG & non PG Lesions depend on mucosal condition, pre, intra & sub epithelial. Quality of healing : o Epithelial repair & renewal o Epithel condition / apoptosis o Mucus production to protect mucosa o Pg concentration o Epithelial growth factors : > Epidermal growth factor > TGF alfa (transforming growth factor alfa) > FGF (fibroblast growth factor)
Basson MD, AJP 161/4,2002 Epidermal growth factor: Inhibited gastric seceretion Promoted ulcer healing Hideyuki Shibata et al, Jpn Pharmacol Ther 26/8,1998 Hideyuki Shibata et al, Jpn Pharmacol Ther 26/8,1998 Conclusions of GU healing : Balanced theory is the basic mechanism of gastric mucosal lesion. The role of defensive factors more influence on gastric mucosal lesion & outcome of healing Many factors in defensive mechanism related to each other to prevent gastric mucosal lesion To increase defensive factors have important role on treatment of gastric mucosal lesion , especially for quality of healing
FUCOIDAN Fucoidan is a complex sulfated polysaccharide, derived from marine brown algae characterized by the main constituents of fucose and sulfate radical and galactose, xylose or uronic acid. Fucoidans have many biological activities : a. Anticoagulant b. Activators AT III and heparin cofactor c. Inhibit initial binding of sperm for penetration of the human pellucide zone d. Blocks the infection of human cells line in several viral infection, HIV, herpes and CMV The mechanism of the anti-ulcer effect was considered to be acceleration of ulcer repair by the increased production of cell growth such as a. epithelial growth factor (EGF) b. Fibroblast growth factor (FGF) Hideyuki S, Masato N, Yumi T et.al Anti-ulcer effect of fucoidan from brown seaweed, Cladosiphon okamuranus TOKIDA, in rats the increase in the EGF content in stomach was found as one of its physiological activities Yoshihiro Y, Tsuyoshi S and Masanori H Effect of mozuku-derived fucoidan and fucoidan- containing tea on gastric ulcer and non-ulcer dyspepsia : 1. Effect of the fucoidan sachet on subjective and objective symptoms were improved in 4 (66%) out of 6 subjects who complained of the symptoms before the administration 2. Severity of H pylori infection by the fucoidan sachet by performing the 13C-urea breath test the 13C-urea value decreased in 4 out of 7 subject but the value increased slightly in 2 subject
3. Effect of the fucoidan-containing tea on subject symptoms a. Changes in the symptoms such as heavy stomach and heartburn the success rate of 100mg fucoidan was 60%(40% in the placabo group) and that of 300mg fucoidan was 90%(60% in the placebo group) b. The subjective symptoms revealed that stomach condition was improved in 4 out of 10 subjects by drinking 100mg fucoidan (1 out of 10 in the placebo group) and 5 out of 10 subjects by drinking 300mg fucoidan (3 out of 10 in the placebo group) 4.Comparison with respect to the drinking period of the fucoidan containing tea The fucoidan-containing tea drinking period was given as the period of best condition most frequently in both groups with 100 and 300 fucoidan. The effect was not significant in the placebo group. 5.Effect of the fucoidan-containing tea on the body mild constipation was noted in 4 out of 20 subjects in the drinking period of the fucoidan and 2 out of 20 subjects in the placebo group.
Juffrie M, Rosalina I, Damayanti W et al. 17 patients fucoidan 100 mg and 16 patients placebo (3 weeks) significant improvement of grade of the ulcer in the fucoidan groups 94%(16/17) compare to the placebo group 37,5% (6/16) p:0,005 significant reduction of abdominal pain after five days p:0,04 vomiting tends to decrease in days 6 p:0,9 Distended was significant decreased in days 3 p:0,02 Hyperacidity causes gastric injury, and in severe situations, ulcer could develop. The growth factors known as the basic fibroblast growth factor (bFGF) and the epidermal growth factor (EGF) have been recognized to promote ulcer healing. Fucoidan is extracted from a brown seaweed of Okinawa called Mozuku or Cladosiphon okamuranus. Fucoidan is effective for the healing of gastric ulcers by inducing epithelial cells to produce growth factors. There was significant improvement of grade of the ulcer in the fucoidan group 94% (16/17) compare to placebo group 37.5% (6/16)
Figure3. Abdominal pain after 5 days observation
Abdominal pain 0 5 10 15 20 25 30 35 1 2 3 4 5 days p e r c e n t fucoidan placebo Figure 4. Vomiting after 6 days observation
Vomiting 0 5 10 15 20 25 1 2 3 4 5 6 days p e r c e n t fucoidan placebo Figure 5. Distended after 5 days observation
Distended 0 5 10 15 20 25 30 1 2 3 4 5 days p e r c e n t fucoidan placebo Ulcer cause by acute gastritis The damage cause by : trauma, burns, sepsis, liver and renal failures and shock, or certain drug such as NSAID This study showed fucoidan is strongly has anti gastric ulcer effect Fucoidan from Cladosiphon binds proteins, inhibits peptides activity and prevent the bFGF instability, as anti ulcer Cladosiphon fucoidan does not stimulate supreoxide generation and TNFalpha secretion by inflammation cells CF has an effect on the bFGF stabilizing activity by sulfated polysaccharides stabilize bFGF by binding to the peptide